- ISIN
- IL0010941198
- CUSIP
- M6240T109
- Sector
- Healthcare
- IPO Date
- May 31, 2013
Highlights
- Market Cap
- $424.42M
- Enterprise Value
- $403.13M
- EPS (TTM)
- $0.34
- PE Ratio
- 20.85
- PEG Ratio
- 6.31
- Total Revenue (TTM)
- $181.68M
- Gross Profit (TTM)
- $74.77M
- EBITDA (TTM)
- $38.26M
- Year Range
- $6.50 - $9.35
- Target Price
- $12.00
- ROA (TTM)
- 5.32%
- ROE (TTM)
- 7.85%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
KMDA Performance Chart
Kamada (KMDA) is up 4.9% since the beginning of the year. At $7 per share, KMDA is trading 23.1% below its 52-week high of $9. Investors who bought $1,000 worth of KMDA shares 5 years ago would now be looking at an investment worth $1,323.
Loading charts...
Returns By Period
Kamada (KMDA) has returned 4.93% so far this year and 2.89% over the past 12 months. Over the last ten years, KMDA has returned 7.64% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Kamada
- 1D
- -1.64%
- 1M
- -8.17%
- YTD
- 4.93%
- 6M
- 4.78%
- 1Y
- 2.89%
- 3Y*
- 12.16%
- 5Y*
- 5.76%
- 10Y*
- 7.64%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
KMDA Monthly Returns History
Based on dividend-adjusted daily data since May 31, 2013, KMDA's average daily return is +0.03%, while the average monthly return is +0.45%. At this rate, an investment would double in approximately 12.9 years.
Historically, 48% of months were positive and 52% were negative. The best month was Nov 2019 with a return of +42.1%, while the worst month was May 2014 at -44.0%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.
On a daily basis, KMDA closed higher 45% of trading days. The best single day was Dec 6, 2023 with a return of +20.9%, while the worst single day was May 16, 2014 at -34.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.85% | 4.57% | -1.23% | -2.40% | -4.05% | -7.94% | 4.93% | ||||||
| 2025 | 10.51% | 2.38% | -1.31% | -2.12% | 5.87% | 13.14% | -4.65% | -6.36% | 0.29% | -0.29% | -3.18% | 5.37% | 19.25% |
| 2024 | -6.37% | 9.95% | -10.95% | -6.95% | 0.96% | -5.88% | 13.91% | 1.77% | -6.61% | 6.89% | 2.61% | 3.40% | -0.49% |
| 2023 | 16.71% | -7.69% | 7.52% | 0.32% | 3.65% | 9.21% | -6.54% | 16.63% | -7.13% | -20.79% | 11.82% | 29.39% | 52.62% |
| 2022 | -8.05% | -8.26% | -0.54% | -2.72% | -16.01% | -0.00% | 13.75% | -2.73% | -9.62% | -0.00% | 4.21% | -14.68% | -39.06% |
| 2021 | -0.15% | -5.10% | 0.81% | -2.58% | -2.65% | -0.85% | -6.53% | -1.10% | -1.49% | 7.74% | 9.11% | 5.62% | 1.54% |
Benchmark Metrics
Kamada has an annualized alpha of -0.43%, beta of 0.57, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since May 31, 2013.
- This stock participated in 93.82% of S&P 500 Index downside but only 39.51% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.57 may look defensive, but with R2 of 0.05 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -0.43%
- Beta
- 0.57
- R²
- 0.05
- Upside Capture
- 39.51%
- Downside Capture
- 93.82%
Return for Risk
Risk / Return Rank
KMDA ranks 43 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Kamada (KMDA) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KMDA | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.95 | ||
| Sortino ratioReturn per unit of downside risk | -2.36 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.37 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | 0.14 | 2.78 | -2.64 |
| Martin ratioReturn relative to average drawdown | 0.26 | 12.44 | -12.18 |
Dividends
Dividend History
Kamada provided a 3.48% dividend yield over the last twelve months, with an annual payout of $0.25 per share.
| Period | TTM | 2025 |
|---|---|---|
| Dividend | $0.25 | $0.20 |
Dividend yield | 3.48% | 2.83% |
Monthly Dividends
The table displays the monthly dividend distributions for Kamada. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.00 | $0.25 | ||||||
| 2025 | $0.20 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.20 |
Dividend Yield & Payout
Dividend Yield
Kamada has a dividend yield of 3.48%, which is quite average when compared to the overall market.
Payout Ratio
Kamada has a payout ratio of 55.45%, which is quite average when compared to the overall market. This suggests that Kamada strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Kamada. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Kamada was 82.46%, occurring on Nov 25, 2014. The portfolio has not yet recovered.
The current Kamada drawdown is 56.46%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2014 bear market2014 | -82.46%Nov 2014 | 8mo 24d | — | 12y 3moMar 2014 - now |
2013 correction2013 | -16.52%Oct 2013 | 15d | 2mo 19d | 3mo 4dOct 2013 - Jan 2014 |
2014 correction2014 | -12.82%Jan 2014 | 7d | 28d | 1mo 5dJan 2014 - Feb 2014 |
2013 pullback2013 | -8.30%Aug 2013 | 20d | 15d | 1mo 5dAug 2013 - Sep 2013 |
2013 pullback2013 | -6.83%Jun 2013 | 2d | 6d | 8dJun 2013 - Jun 2013 |
Drawdown Indicators
| KMDA | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.46% | -56.78% | -25.68% |
Max Drawdown (1Y)Largest decline over 1 year | -20.65% | -9.10% | -11.55% |
Max Drawdown (3Y)Largest decline over 3 years | -28.99% | -18.90% | -10.09% |
Max Drawdown (5Y)Largest decline over 5 years | -44.43% | -25.43% | -19.00% |
Max Drawdown (10Y)Largest decline over 10 years | -67.69% | -33.92% | -33.77% |
Current DrawdownCurrent decline from peak | -56.46% | -1.80% | -54.66% |
Average DrawdownAverage peak-to-trough decline | -62.95% | -10.71% | -52.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.97% | 2.03% | +8.94% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Kamada over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Kamada is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for KMDA, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/E ratio of 20.9. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for KMDA compared to other companies in the Drug Manufacturers - Specialty & Generic industry. KMDA currently has a PEG ratio of 6.3. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for KMDA relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/S ratio of 2.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for KMDA in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with KMDA
Add Kamada to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with KMDA